Exodus Point Capital Management, LP Harpoon Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$1.78 - $5.02 $19,240 - $54,261	-10,809 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.54 - $8.08 $38,263 - $87,336	10,809 New	10,809 $54,000
Q4 2021 Feb 11, 2022	SELL	$5.69 - $7.83 $260,215 - $358,081	-45,732 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $360,368 - $640,248	45,732 New	45,732 $361,000
Q2 2021 Aug 16, 2021	SELL	$13.81 - $23.25 $197,165 - $331,940	-14,277 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $251,989 - $344,932	14,277 New	14,277 $299,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.